Clinical trial
Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease
NCT06775964 is registered in ClinicalTrials.gov with Paul E Schulz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mesenchymal Stem Cell Therapy for Early Alzheimer's Disease
- Lead sponsor
- Paul E Schulz
- Phase
- Phase 1/2
- Overall status
- Recruiting
- Start date
- March 11, 2026
- Completion date
- January 31, 2028
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.